van Andel G - Search Results

1

[Follow-up investigation in urologic oncology, in particular nephrectomy due to renal cell carcinoma].

van Bezooijen BP, van Andel G, Horenblas S. van Bezooijen BP, et al. Among authors: van andel g. Ned Tijdschr Geneeskd. 2003 Aug 2;147(31):1496-500. Ned Tijdschr Geneeskd. 2003. PMID: 12924079 Review. Dutch.

2

Van Andel G, Visser AP, Hulshof MC, Horenblas S, Kurth KH. Van Andel G, et al. BJU Int. 2003 Aug;92(3):217-22. doi: 10.1046/j.1464-410x.2003.04321.x. BJU Int. 2003. PMID: 12887470

3

A prospective longitudinal study comparing the impact of external radiation therapy with radical prostatectomy on health related quality of life (HRQOL) in prostate cancer patients.

van Andel G, Visser AP, Zwinderman AH, Hulshof MC, Horenblas S, Kurth KH. van Andel G, et al. Prostate. 2004 Mar 1;58(4):354-65. doi: 10.1002/pros.10342. Prostate. 2004. PMID: 14968436

4

Real-world outcomes of first-line chemotherapy for unresectable stage III and IV bladder cancer.

Reesink DJ, van Melick HHE, van der Nat PB, Los M, Horenblas S, van de Garde EMW; Santeon MIBC Study Group. Reesink DJ, et al. World J Urol. 2023 Jun;41(6):1551-1562. doi: 10.1007/s00345-023-04408-w. Epub 2023 May 5. World J Urol. 2023. PMID: 37145158

5

Incidental carcinoma of the prostate.

van Andel G, Vleeming R, Kurth K, de Reijke TM. van Andel G, et al. Semin Surg Oncol. 1995 Jan-Feb;11(1):36-45. doi: 10.1002/ssu.2980110106. Semin Surg Oncol. 1995. PMID: 7538693 Review.

6

A randomized study comparing epirubicin in a 4-weekly versus a weekly intravenous regimen in patients with metastatic, hormone resistant, prostatic carcinoma: effects on health related quality of life.

van Andel G, Fernandez de Moral P, Caris CT, Carpentier P, Wils J, de Bruin MJ, Witjes JA, Debruyne FM, Witjes WP. van Andel G, et al. World J Urol. 2003 Aug;21(3):177-82. doi: 10.1007/s00345-003-0342-3. Epub 2003 Jun 18. World J Urol. 2003. PMID: 12819912 Clinical Trial.

7

C reactive protein in the diagnosis of acute appendicitis.

Oosterhuis WP, Zwinderman AH, Teeuwen M, van Andel G, Oldenziel H, Kerkhoff JF, Siebbeles HW, van der Helm HJ. Oosterhuis WP, et al. Among authors: van andel g, van der helm hj. Eur J Surg. 1993 Feb;159(2):115-9. Eur J Surg. 1993. PMID: 8098625

8

Does prostate-specific antigen density alter decision making on biopsy?

Vleeming R, de Craen AJ, de Reijke TM, van Andel G, Kurth KH. Vleeming R, et al. Among authors: van andel g. Eur Urol. 1996;29(1):10-14. doi: 10.1159/000473710. Eur Urol. 1996. PMID: 8821683

9

Quality of life in patients with prostatic carcinoma: a review and results of a study in N+ disease. Prostate-specific antigen as predictor of quality of life.

van Andel G, Kurth KH, de Haes JC. van Andel G, et al. Urol Res. 1997;25 Suppl 2:S79-88. doi: 10.1007/BF00941993. Urol Res. 1997. PMID: 9144892 Review.

10

Quality-of-life assessment in bladder cancer.

van der Veen JH, van Andel G, Kurth KH. van der Veen JH, et al. Among authors: van andel g. World J Urol. 1999 Aug;17(4):219-24. doi: 10.1007/s003450050136. World J Urol. 1999. PMID: 10460404 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

61 results

Search Page